Apotea AB (publ) (STO:APOTEA)
Sweden · Delayed Price · Currency is SEK 72.25
+0.10 (0.14%)
Aug 12, 2026, 11:08 AM CET
Apotea AB Market Cap
Apotea AB has a market cap or net worth of 7.51 billion as of August 11, 2026. Its market cap has decreased by -37.26% in one year.
Market Cap
7.51B
Enterprise Value
7.70B
Revenue
7.59B
Ranking
n/a
PE Ratio
30.57
Stock Price
72.25
ChartMarket Cap Chart
Since December 6, 2024, Apotea AB's market cap has decreased from 8.63B to 7.51B, a decrease of -13.00%. That is a compound annual growth rate of -7.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 7.51B | -21.76% |
| Dec 30, 2025 | 9.60B | 9.72% |
| Dec 30, 2024 | 8.75B | 1.35% |
| Dec 6, 2024 | 8.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 157.39B |
| Getinge AB | 65.15B |
| Sectra AB | 52.21B |
| Camurus AB | 36.12B |
| BioGaia AB | 11.28B |
| Xvivo Perfusion AB | 8.78B |
| MedCap AB | 7.95B |
| Synsam AB | 7.89B |